News

Dexcel had filed its new drug application (NDA) with a paragraph IV certification stating that AstraZeneca’s patents are invalid, unenforceable, or will not be infringed under the NDA.

Operating profit in the third quarter was $2.02 billion, down 7%. Operating profit was reduced by restructuring costs of $146 million and by $212 million from the inclusion

The results are consistent with the large safety database already accumulated on the individual constituents fluticasone and formoterol. The study involved 472 patients who were treated with Flutiform

The study is a single-center, randomized, placebo-controlled, double-blind, parallel group assessment of the multiple-dose efficacy of ibuprofen 600mg ER, enrolling approximately 150 patients. The primary objective is to

The trial was part of a National Cancer Institute funded cooperative group study conducted by the Children’s Oncology Group (COG). The data is based on long-term follow up

The objective of this trial is to generate proof-of-concept data to evaluate the efficacy and safety, including neuropathy, of picoplatin in combination with 5-fluorouracil (5-FU) and leucovorin, Folpi

The Phase Ib, open-label single-arm clinical trial is expected to enroll up to 40 relapsed or refractory multiple myeloma patients at multiple sites in the US. Patients will

Under the terms of the agreement, Neurocrine will receive an initial payment of $20 million and an additional $10 million payment upon FDA approval of indiplon. Neurocrine is

Lansoprazole is used to treat gastrointestinal diseases including acid reflux and ulcers and is marketed under the trade name Prevacid in the US by TAP and in Europe